Efficacy and tolerability of bevacizumab in patients with severe Covid-19.
Pang J, Xu F, Aondio G, Li Y, Fumagalli A, Lu M, Valmadre G, Wei J, Bian Y, Canesi M, Damiani G, Zhang Y, Yu D, Chen J, Ji X, Sui W, Wang B, Wu S, Kovacs A, Revera M, Wang H, Jing X, Zhang Y, Chen Y, Cao Y.
Pang J, et al. Among authors: zhang y.
Nat Commun. 2021 Feb 5;12(1):814. doi: 10.1038/s41467-021-21085-8.
Nat Commun. 2021.
PMID: 33547300
Free PMC article.
Clinical Trial.